| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document

Title:PRIMER NABAVE V GENERIČNEM FARMACEVTSKEM PODJETJU
Authors:ID Valenčič, Rok (Author)
ID Strašek, Sebastjan (Mentor) More about this mentor... New window
Files:.pdf VS_Valencic_Rok_2016.pdf (1,29 MB)
MD5: 99C4B249BEF6774BE1E73F2EFA42B6B5
 
Language:Slovenian
Work type:Undergraduate thesis (m5)
Typology:2.11 - Undergraduate Thesis
Organization:EPF - Faculty of Business and Economics
Abstract:Farmacevtska industrija se v današnjem svetu hitrih sprememb ne sooča le s hudo konkurenco, ampak tudi z omejitvami državnih regulatorjev pri prodaji zdravil. Načelo »cenejše zdravilo je lahko enako dobro« je takorekoč zakoreninjeno že v vseh zdravstvenih sistemih po svetu. Razlog za to je v klestenju stroškov zdravstvenih storitev. Preživetje podjetja danes ni odvisno le od vse tesnejšega sodelovanja ter zadostnih vlaganj v znanost in razvoj, ampak tudi od učinkovitosti proizvodnih procesov. Eden od teh je nabavni, ki je v generičnem farmacevtskem podjetju ključni za nakup kakovostnih surovin za izdelavo bioekvivalentnih zdravil. Za razumevanje vseh teh področij sem opisal tudi razmere na farmacevtskem trgu in politiko določanja cen originalnim (referenčnim) in generičnim zdravilom.
Keywords:svetovni farmacevtski trg, originatorji, generiki, patent, nabava
Year of publishing:2016
Publisher:[R. Valenčič]
Source:Maribor
PID:20.500.12556/DKUM-58365 New window
UDC:658.7
COBISS.SI-ID:12413980 New window
NUK URN:URN:SI:UM:DK:VGGVBVCM
Publication date in DKUM:01.08.2016
Views:1075
Downloads:136
Metadata:XML RDF-CHPDL DC-XML DC-RDF
Categories:EPF
:
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:AddThis
AddThis uses cookies that require your consent. Edit consent...

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Secondary language

Language:English
Title:PROCUREMENT EXAMPLE IN GENERIC PHARMACEUTICAL ENTERPRISE
Abstract:Rash development nowadays does not only force pharmaceutical industry to face fierce competition but it also has to deal with strict national drug selling regulations. The principle ‘the cheaper of the drugs is as effective as the expensive one’ is present in all health systems. The reason for that is the reduction of costs. A company’s viability does not depend only on close collaboration and adequate investments in research and development, but also on production process effectiveness. One of these processes is procurement that represents the key factor for the supply of raw material which is used in bioequivalent drugs production. Pharmaceutical market situation and the policy for determining originator and generic drugs pricing are essential for understanding the complexity of the pharmaceutical industry.
Keywords:world pharmaceutical market, originators, generics, patent, procurement


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica